Skip to Main Content

Paper Details

Brain Distribution of Berzosertib: An Ataxia Telangiectasia and Rad3-Related Protein Inhibitor for the Treatment of Glioblastoma.
J Pharmacol Exp Ther
7
2021
ATR, Ataxia Telangiectasia, Berzosertib, GBM, Glioblastoma, Glioblastoma multiforme, Rad3-Related Protein, ataxia telangiectasia, ataxia telangiectasia and Rad3-related protein, berzosertib, brain tumors, cancer, cancer cells, glioblastoma multiforme, intracranial tumor, patient, primary brain tumor, temozolomide, tumor
Author NameAffiliation
Ranjit S BindraBrain Barriers Research Center, Department of Pharmaceutics, University of Minnesota, Mayo Clinic, Yale School of Medicine
Jann N SarkariaBrain Barriers Research Center, Department of Pharmaceutics, University of Minnesota, Mayo Clinic, Yale School of Medicine
  • 1 - 2

Datasets

Release 1.2